Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,362 | -9,718 | -6,444 | -7,180 | -4,159 |
| Depreciation Amortization | 701 | 529 | 356 | 746 | 410 |
| Other Working Capital | 392 | -358 | -3,084 | -1,669 | 97 |
| Other Operating Activity | 264 | -75 | -190 | 172 | 38 |
| Operating Cash Flow | $-12,005 | $-9,622 | $-9,362 | $-7,931 | $-3,614 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,206 | 189 | 129 | -5,000 | -107 |
| PPE Investments | -482 | -247 | -55 | -1,384 | -851 |
| Other Investing Activity | 0 | 0 | 0 | 13 | 13 |
| Investing Cash Flow | $4,724 | $-58 | $74 | $-6,371 | $-945 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 32,452 | 31,980 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $32,452 | $31,980 |
| Exchange Rate Effect | 8 | 133 | 93 | -232 | 646 |
| Beginning Cash Position | 23,649 | 23,649 | 23,649 | 5,731 | 5,681 |
| End Cash Position | 16,376 | 14,102 | 14,454 | 23,649 | 33,748 |
| Net Cash Flow | $-7,273 | $-9,547 | $-9,195 | $17,918 | $28,067 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,005 | -9,622 | -9,362 | -7,931 | -3,614 |
| Capital Expenditure | -482 | -247 | -55 | -1,384 | -851 |
| Free Cash Flow | -12,487 | -9,869 | -9,417 | -9,315 | -4,465 |